Your browser doesn't support javascript.
loading
Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules.
Bethune, Michael T; Li, Xiao-Hua; Yu, Jiaji; McLaughlin, Jami; Cheng, Donghui; Mathis, Colleen; Moreno, Blanca Homet; Woods, Katherine; Knights, Ashley J; Garcia-Diaz, Angel; Wong, Stephanie; Hu-Lieskovan, Siwen; Puig-Saus, Cristina; Cebon, Jonathan; Ribas, Antoni; Yang, Lili; Witte, Owen N; Baltimore, David.
  • Bethune MT; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125.
  • Li XH; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095.
  • Yu J; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095.
  • McLaughlin J; Molecular Biology Institute, University of California, Los Angeles, CA 90095.
  • Cheng D; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095.
  • Mathis C; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095.
  • Moreno BH; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA 90095.
  • Woods K; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, CA 90095.
  • Knights AJ; Cancer Immunobiology Laboratory, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, VIC 3084, Australia.
  • Garcia-Diaz A; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia.
  • Wong S; Cancer Immunobiology Laboratory, Ludwig Institute for Cancer Research, Heidelberg, VIC 3084, Australia.
  • Hu-Lieskovan S; Cancer Immunobiology Laboratory, Ludwig Institute for Cancer Research, Heidelberg, VIC 3084, Australia.
  • Puig-Saus C; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, CA 90095.
  • Cebon J; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125.
  • Ribas A; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, CA 90095.
  • Yang L; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, CA 90095.
  • Witte ON; Cancer Immunobiology Laboratory, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, VIC 3084, Australia.
  • Baltimore D; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia.
Proc Natl Acad Sci U S A ; 115(45): E10702-E10711, 2018 11 06.
Article en En | MEDLINE | ID: mdl-30348802

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Proteínas de Homeodominio / Complejo Mayor de Histocompatibilidad Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Proteínas de Homeodominio / Complejo Mayor de Histocompatibilidad Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article